Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
28.66
+0.84 (3.02%)
At close: Mar 9, 2026, 4:00 PM EDT
28.62
-0.04 (-0.14%)
After-hours: Mar 9, 2026, 7:45 PM EDT
Edgewise Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -167.8 | -133.81 | -100.16 | -67.64 | -42.81 | |
| Depreciation & Amortization | 2.27 | 2.29 | 1.73 | 0.54 | 0.27 | |
| Loss (Gain) From Sale of Investments | -7.67 | -12.55 | -9.52 | -0.54 | - | |
| Stock-Based Compensation | 34.75 | 24.71 | 17.56 | 10.92 | 4.4 | |
| Change in Accounts Payable | 0.27 | 1.74 | -0.09 | 0.05 | 2.65 | |
| Change in Other Net Operating Assets | -5.65 | 8.59 | -1.47 | 4.04 | 1.98 | |
| Operating Cash Flow | -143.82 | -109.03 | -91.95 | -52.64 | -33.51 | |
| Capital Expenditures | -0.26 | -1.31 | -5.75 | -5.55 | -0.67 | |
| Investment in Securities | -32.53 | -183.34 | 108.63 | -65.03 | -241.56 | |
| Investing Cash Flow | -32.79 | -184.66 | 102.89 | -70.58 | -242.23 | |
| Issuance of Common Stock | 196.09 | 249.52 | 53.33 | 129.89 | 186.51 | |
| Other Financing Activities | - | -0.26 | -0.17 | -0.25 | -0.12 | |
| Financing Cash Flow | 196.09 | 249.25 | 53.17 | 129.64 | 186.38 | |
| Net Cash Flow | 19.48 | -44.43 | 64.1 | 6.43 | -89.35 | |
| Free Cash Flow | -144.07 | -110.34 | -97.69 | -58.18 | -34.18 | |
| Free Cash Flow Per Share | -1.40 | -1.19 | -1.53 | -1.09 | -0.91 | |
| Levered Free Cash Flow | -87.34 | -63.22 | -61.66 | -35.48 | -19.26 | |
| Unlevered Free Cash Flow | -87.34 | -63.22 | -61.66 | -35.48 | -19.26 | |
| Change in Working Capital | -5.37 | 10.33 | -1.56 | 4.09 | 4.63 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.